- Home
- THTX vs SYRS Comparison
THTX vs SYRS Comparison
Compare THTX & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- SYRS
- Stock Information
- Founded
- THTX 1993
- SYRS 2011
- Country
- THTX Canada
- SYRS United States
- Employees
- THTX N/A
- SYRS N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- THTX Health Care
- SYRS Health Care
- Exchange
- THTX Nasdaq
- SYRS Nasdaq
- Market Cap
- THTX 56.1M
- SYRS 52.5M
- IPO Year
- THTX N/A
- SYRS 2016
- Fundamental
- Price
- THTX $1.18
- SYRS $0.26
- Analyst Decision
- THTX Hold
- SYRS Hold
- Analyst Count
- THTX 1
- SYRS 5
- Target Price
- THTX N/A
- SYRS $3.00
- AVG Volume (30 Days)
- THTX 29.7K
- SYRS 4.1M
- Earning Date
- THTX 10-10-2024
- SYRS 10-31-2024
- Dividend Yield
- THTX N/A
- SYRS N/A
- EPS Growth
- THTX N/A
- SYRS N/A
- EPS
- THTX N/A
- SYRS N/A
- Revenue
- THTX $84,316,000.00
- SYRS $386,000.00
- Revenue This Year
- THTX $5.60
- SYRS N/A
- Revenue Next Year
- THTX $4.62
- SYRS $1,011.11
- P/E Ratio
- THTX N/A
- SYRS N/A
- Revenue Growth
- THTX 5.75
- SYRS N/A
- 52 Week Low
- THTX $1.08
- SYRS $0.25
- 52 Week High
- THTX $2.58
- SYRS $8.17
- Technical
- Relative Strength Index (RSI)
- THTX 40.63
- SYRS 27.55
- Support Level
- THTX $1.21
- SYRS $2.41
- Resistance Level
- THTX $1.28
- SYRS $3.40
- Average True Range (ATR)
- THTX 0.07
- SYRS 0.30
- MACD
- THTX -0.01
- SYRS -0.26
- Stochastic Oscillator
- THTX 9.37
- SYRS 0.33
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.